NSF Hosts 11th Symposium on Medical Technology in Hamburg
The MedTech world has changed significantly. Global supply chains have been disrupted, travel restrictions have been put in place and social interactions have shifted into the digital space; economic downturns required new ways of thinking, and new technologies have emerged. During the pandemic years, resilient health care systems have become much more appreciated, and regulators have become more agile around the world. Over the last decade, medical devices have been regulated with more clinical focus, in addition to generic regulations (on cybersecurity, artificial intelligence, environmental protection, etc.).
Coming out of a five-plus-year overhaul of the EU regulatory landscape for medical devices and IVDs, the outlook beyond 2022 becomes more global again. With lessons learned from a worldwide pandemic, the economic survival of MedTech will depend on new drivers:
- Advanced technologies have become an integral part of the design and manufacturing of the next generation of “intelligent” medical devices and IVDs.
- Sustainability/ESG will become a more and more significant differentiator. The dual prevention for both human and planetary health is a double opportunity.
- Global compliance is a prerequisite for market access and needs agile processes to master constantly changing global regulations.
NSF, together with Life Sciences Nord (LSN), hosted its annual medical technology symposium in Hamburg, Germany, on September 15-16. The symposium highlighted why advanced technologies and sustainability expectations will reshape the economic landscape for the MedTech industries and how an adaptive approach to global compliance makes a significant difference.
The event brought together more than 65 leading medical device experts from around the world to discuss new drivers for MedTech survival in a market emerging from EU regulatory overhauls and a global pandemic. It featured speakers from BVMed, Eppendorf Group, Olympus, Medtronic, Siemens Healthineers, Microsoft, BSI and other organizations.
"Advanced technologies and sustainability expectations are reshaping the economic landscape for MedTech. After the last decade, this industry is now not only regulated with more clinical focus, but evaluated on cybersecurity, artificial intelligence and environmental protection too. With the pandemic shifting regulators to be more agile and a greater appreciation for resilient health care, now is the time for an adaptive approach to global compliance in MedTech."
- Oliver Christ, Global Managing Director, Medical Devices and IVD Consulting, NSF
Over two days, experts examined how manufacturers can build resilience in the next generation of medical devices. Featured speakers discussed integrating advanced technologies and intelligence, differentiating through embracing sustainability and ESG in design, and creating the agility needed to navigate global regulatory compliance to ensure market access.
This is the first time the symposium was conducted in English, which enabled broader international audience participation and high engagement.
Agenda - September 15th
Sustainability/ESG | ||
---|---|---|
8:30am - 9:00am | Registration and Networking | |
9:00am - 9:20am | Welcome and Opening | Oliver Christ | NSF |
9:20am - 10:00am | Future in MedTech: Technology, Sustainability & Global Compliance | Pedro Sancha | President and CEO of NSF |
10:00am - 10:40am | Digitalization vs Compliance as an Enabler for Growth | Sebastian Retter & Peter Felst | Mazars |
10:40am - 11:00am | Break and Networking | |
11:00am - 11:40am | Latest News on EU Medical Device Regulations and Beyond | Dr. Katja Marx | BVMed |
11:40am - 12:20pm | Managing Sustainability in a Life Science Company | Anna-Lena Hoffmann & Enrico Jakobi | Eppendorf Group |
12:20pm - 1:00pm | Sustainability for MedTech Industry – In Context of Health Care | Dr. Maike Möller & Robert Speer | NSF |
1:00pm - 2:00pm | Lunch and Networking |
Advanced Technology | ||
---|---|---|
2:00pm - 2:35pm | EU Commission’s Draft Regulation for a European Health Data Space and Its Possible Implications on the Medical Device Industry | Susanna Dienemann | Wachenhausen Law firm |
2:35pm - 3:10pm | Global Regulatory Roundup Using Artificial Intelligence in Medical Devices | Jan-Michael Krüger & Merle Streppel | Olympus |
3:10pm - 3:30pm | International Standardization of AI and the Role of Snaig | Patty Krantz-Zuppan | Medtronic Regina Rosina Geierhofer | Siemens Healthineers |
3:30pm - 4:00pm | Break and Networking | |
4:00pm - 4:45pm | Digitization as an Enabler To Transform MedTech | Claudia Alsdorf | Microsoft |
4:45pm - 5:30pm | Clinical Evaluation: Compliance of Medical Devices With AI | Rachel Mead | BSI Group |
5:30pm - 6:00pm | Summary: Q&A | |
6:00pm - 8:00pm | Welcome and Reception Opening | Prof. Dr. Heike Wachenhausen | Life Science Nord Dr. Jürgen Walkenhorst | Life Science Nord |
Agenda - September 16th
Global Compliance | ||
---|---|---|
9:00am - 9:10am | Welcome and Opening | Oliver Christ | NSF |
9:10am - 9:50am | How AI and Other Emerging Technologies Effect the Future of Medical Devices | Ronny Stoll | NSF |
9:50am - 10:30am | Embracing the IVDR Transition From IVDD to IVDR – Mastering a Regulatory Challenge | Magali Wolff | TECAN Kai Ohlroggen | TECAN |
10:30am - 10:45am | Dialog: Q&A | |
10:45am - 11:10am | Break and Networking | |
11:10am - 12:00pm | Symposium Summary Panel: Future Compliance Goes Beyond MD Regulations Sustainability and IT Compliance Are Equally Important! | Heather Howell | NSF Lesley Ma | NSF |
12:00pm - 12:45pm | The Double Prevention – A Global Outlook in a Post-Pandemic World | Oliver Christ | NSF |
12:45pm - 1:00pm | Closing Remarks | |
1:00pm - 2:00pm | Lunch |
Share this Article
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.